Title:
COMBINATION THERAPY FOR TREATING CANCER
Document Type and Number:
Japanese Patent JP2023126957
Kind Code:
A
Abstract:
To provide a combination therapy for the treatment of cancer.SOLUTION: The present disclosure relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents (such as tyrosine kinase inhibitors or VEGF/VEGFR inhibitors), particularly anticancer agents such as sunitinib, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.SELECTED DRAWING: Figure 1
Inventors:
HEIKE KEILHACK
ROBERTO PILI
ROBERTO PILI
Application Number:
JP2023111904A
Publication Date:
September 12, 2023
Filing Date:
July 07, 2023
Export Citation:
Assignee:
EPIZYME INC
HEALTH RESEARCH INC
HEALTH RESEARCH INC
International Classes:
A61K45/06; A61K31/404; A61K31/44; A61K31/4412; A61K31/444; A61K31/4545; A61K31/47; A61K31/496; A61K31/502; A61K31/506; A61K31/517; A61K31/5377; A61K31/553; A61K39/395; A61P35/00; A61P43/00
Attorney, Agent or Firm:
Koji Murai
Previous Patent: Use of split deaminase to limit unwanted off-target base editor deamination
Next Patent: playing cards
Next Patent: playing cards